---
schema_version: "secwatch.filing_event.v1"
accession: "0001035267-24-000244"
form_type: "8-K"
ticker: "ISRG"
cik: "0001035267"
company_name: "INTUITIVE SURGICAL INC"
filed_at: "2024-10-17T23:59:59+00:00"
generated_at: "2026-05-30T13:00:08.350263+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Intuitive Surgical Q3 revenue $2.04B (+17% YoY); GAAP EPS $1.56, non-GAAP $1.84

## Summary
- da Vinci procedures grew 18% YoY; placed 379 systems including 110 da Vinci 5 units.
- Revenue $2.04B; instruments/accessories +18% to $1.26B; systems revenue $445M.
- GAAP net income $565M ($1.56/diluted share) vs $416M ($1.16) in Q3 2023.
- Non-GAAP net income $669M ($1.84/diluted share) vs $524M ($1.46).
- South Korea regulatory clearance for da Vinci 5 in multiple surgical specialties.

## SEC filing metadata
- accession: 0001035267-24-000244
- form_type: 8-K
- ticker: ISRG
- cik: 0001035267
- company_name: INTUITIVE SURGICAL INC
- filed_at: 2024-10-17T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1035267/000103526724000244/0001035267-24-000244-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1035267/000103526724000244/isrg-20241017.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001035267-24-000244
- JSON: https://secwatch.observer/filing/0001035267-24-000244.json
- Plain text: https://secwatch.observer/filing/0001035267-24-000244.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.